Condition
Liver Abscess, Pyogenic
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed2
Unknown1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07579104CompletedPrimary
Pyogenic Liver Abcess in Guadeloupe
NCT07303829Not ApplicableNot Yet RecruitingPrimary
Laparoscopic Approach to Pyogenic Liver Abscess
NCT05213949UnknownPrimary
An Observational Study of Risk Factors and Long-term Prognosis of Patients With Liver Abscess in the "Real-world"
NCT01723150Phase 4CompletedPrimary
Antibiotics for Klebsiella Liver Abscess Study
Showing all 4 trials